Home
»
Who Survives Cancer?
Who Survives Cancer?
Regular price
€42.99
603 verified reviews
100% verified
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
Shipping & Delivery
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
14-28 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
Close
A01=Howard P. Greenwald
Age Group_Uncategorized
Age Group_Uncategorized
american health care
american treatment of cancer
Author_Howard P. Greenwald
automatic-update
cancer
cancer prevention
cancer treatment availability
Category1=Non-Fiction
Category=JHM
Category=MJC
class and cancer
COP=United States
Delivery_Delivery within 10-20 working days
early detection of cancer
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_society-politics
experimental treatments for cancer
health care and cancer
health care for all
health care in us
health care inequality
inadequate health care for cancer
interdisciplinary cancer research
Language_English
PA=Available
Price_€20 to €50
PS=Active
psychological aspects of cancer
race and cancer
racial factors in surviving cancer
sex and cancer
softlaunch
survivability of cancer for poor
surviving cancer
Product details
- ISBN 9780520302952
- Weight: 454g
- Dimensions: 152 x 229mm
- Publication Date: 14 Aug 2018
- Publisher: University of California Press
- Publication City/Country: US
- Product Form: Paperback
- Language: English
Howard P. Greenwald takes an incisive look at how class, race, sex, psychological state, type of health care, and available treatments affect one’s chance of surviving cancer. Drawing on a ten-year survival study of cancer patients, he synthesizes medical, epidemiological, and psychosocial research in a uniquely interdisciplinary and eye-opening approach to the question of who survives cancer and why.
Scientists, health care professionals, philanthropists, government agencies, and the public all agree that significant resources must be allocated to fight this dreaded disease. But what is the most effective way to do it? Greenwald argues that our priorities have been misplaced and calls for a fundamental rethinking of the way the American medical establishment deals with cancer. He asserts that prevention and experimental therapy have only limited value, whereas the availability of conventional medical care has a greater influence on cancer survival. Class and race become strikingly significant in predicting who has access to health care and thus can obtain medical treatment in a timely, effective manner. Greenwald counters the popular notion that personality and psychological factors strongly affect survival, and he underscores the importance of early detection. His research shows that health maintenance organizations, while sometimes prone to delays, offer low-income patients a better chance of ultimate survival. Greenwald pleads for immediate attention to the inadequacies and inequalities in our health care delivery system that deter patients from seeking early medical care.
Instead of focusing on research and the hope for a breakthrough cure, Greenwald urges renewed emphasis on ensuring available health care to all Americans. In its challenge to the thrust of much biomedical research and its critique of contemporary American health care, as well as in its fresh and often counterintuitive look at cancer survival, Who Survives Cancer? is invaluable for policymakers, health care professionals, and anyone who has survived or been touched by cancer.
This title is part of UC Press's Voices Revived program, which commemorates University of California Press’s mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1992.
Scientists, health care professionals, philanthropists, government agencies, and the public all agree that significant resources must be allocated to fight this dreaded disease. But what is the most effective way to do it? Greenwald argues that our priorities have been misplaced and calls for a fundamental rethinking of the way the American medical establishment deals with cancer. He asserts that prevention and experimental therapy have only limited value, whereas the availability of conventional medical care has a greater influence on cancer survival. Class and race become strikingly significant in predicting who has access to health care and thus can obtain medical treatment in a timely, effective manner. Greenwald counters the popular notion that personality and psychological factors strongly affect survival, and he underscores the importance of early detection. His research shows that health maintenance organizations, while sometimes prone to delays, offer low-income patients a better chance of ultimate survival. Greenwald pleads for immediate attention to the inadequacies and inequalities in our health care delivery system that deter patients from seeking early medical care.
Instead of focusing on research and the hope for a breakthrough cure, Greenwald urges renewed emphasis on ensuring available health care to all Americans. In its challenge to the thrust of much biomedical research and its critique of contemporary American health care, as well as in its fresh and often counterintuitive look at cancer survival, Who Survives Cancer? is invaluable for policymakers, health care professionals, and anyone who has survived or been touched by cancer.
This title is part of UC Press's Voices Revived program, which commemorates University of California Press’s mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1992.
Howard P. Greenwald is Professor in the School of Public Administration at the University of Southern California and the author of Social Problems in Cancer Control.
Who Survives Cancer?
€42.99
